The current body of evidence indicates that berberine can promote the cell cycle arrest of human hepatoma HEPG2 cells in the G1 phase through the upregulation of BTG2 and the downregulation of cyclin D1, consequently inhibiting the proliferation of hepatoma cells and inducing apoptosis. The gene discussed is CCND1; the disease is hepatocellular carcinoma.